Press Releases Grifols, S.A.

Equities

GRF

ES0171996087

Pharmaceuticals

Market Closed - BME Other stock markets 11:35:17 2025-04-23 am EDT			After market 03:59:58 pm
8.394 ^EUR	+0.50%		8.373	-0.25%

Apr. 14	European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	MT
Apr. 08	IBL International Collaborates with Grifols on Advanced Biomarker Panels	CI

Press Releases

Grifols S A : partners with IBL International to develop advanced biomarker panels for unique clinical diagnostics platform	Apr. 08	PU
Grifols S A : appoints Montse Ribas as Chief Communications and Reputation Officer to strengthen the company's global reputation	Apr. 03	PU
Board of Directors Clarifies no knowledge of restarted discussions on potential offer from Brookfield	Apr. 02	AQ
Grifols has approved that its fully owned subsidiary Grifols Biotest Holdings GmbH, to make a public delisting purchase offer to the shareholders of Biotest AG	Mar. 31	AQ
Grifols S A : and Inpeco joining forces to deliver transfusion medicine ‘lab of the future’	Mar. 20	PU
Grifols S A : Phase 2/3 trial shows positive impact of immunoglobulin therapy on post-polio patients	Mar. 13	PU
Grifols Responds to Misleading Media Report	Mar. 10	AQ
Grifols S A : ’ Alternative Performance Measures (b02f1fed 3ef6 7509 6832 6f58c733b65bt1741594463720)	Mar. 10	PU
Grifols S A : Conference call transcript (e5d630f2 399c cb70 78b3 2819ba648a9at1741187817117)	Mar. 05	PU
Grifols Investors & Analyst Meeting 2025	Feb. 28	AQ
2024 Annual Accounts Consolidated and Individual	Feb. 27	AQ
Grifols S A : Presentation (fe6a9486 ded9 fb21 587e a1ebd18380e7t1740588633428)	Feb. 26	PU
Grifols S A : Press Release (1a632c99 7ff8 bd96 2757 6033d32bc8d2t1740588593584)	Feb. 26	PU
Grifols S A : delivers a strong 2024 exceeding guidance on revenue and free cash flow	Feb. 26	PU
Grifols S A : Communication Thomas Glanzmann to retire as Chairman and will be succeeded by Board member Anne Catherine Berner	Feb. 26	PU
Grifols Communication - Thomas Glanzmann to retire as Grifols Chairman and will be succeeded by Board member Anne-Catherine Berner	Feb. 26	AQ
Grifols S A : Thomas Glanzmann to retire as Grifols Chairman and will be succeeded by Board member Anne-Catherine Berner	Feb. 25	PU
Grifols S A : collaborates with startup FcR Therapeutics to develop recombinant therapies for autoimmune diseases	Feb. 04	PU
Grifols pioneers high-tech analysis of plasma bank to detect early signs of Parkinson's disease	Jan. 15	AQ
Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease	Jan. 14	AQ
Grifols S A : submits Biologics License Application for its new fibrinogen solution to U.S. FDA	Jan. 09	PU
Grifols reports on the closing of a private placement of secured bonds and the extension of its revolving credit line	Dec. 23	AQ
Grifols S A : ranked number one biotech company in Dow Jones Sustainability Indices December 16 2024	Dec. 16	PU
Grifols announces private placement of Senior Secured Notes and Revolving Credit Facility extension	Dec. 11	AQ
Grifols S A : concludes balance sheet improvement process with private placement of Senior Secured Notes and Revolving Credit Facility extension December 11 2024	Dec. 11	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GRIFOLS : Q4 24: Investors impressed with FCF generation and governance-related announcements

February 27, 2025 at 12:26 pm EST

Gotham City sets its sights on Grifols

January 09, 2024 at 10:09 am EST